| Autor: |
Jiménez‐Ubieto, A., Poza, M., López‐Pereira, P., Figaredo, G., Sarandeses, P., Martin‐Muñoz, A., Barrio, S., Cortés, M., Íñiguez, R., Zamanillo, I., Oliveira, A., Rodríguez‐Izquierdo, A., Baumann, T., Revilla, E., Gómez‐Rojas, S., Pérez‐Segura, G., Ayala, R., Martínez‐López, J. |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p322-323, 2p |
| Abstrakt: |
PET interim results could promptly select Follicular Lymphoma patients in need of maintenance therapy. PET/CT SB EOT sb were predictive of relapse, with 2-years PFS 47% in PET/CT SB EOT sb (+) vs. 89% in PET/CT SB EOT sb (-) ( I p i <.001).On iPET/CT, 41 (34%) patients were PET/CT(+).The estimated 5 year-PFS at was 72% in patients with a negative iPET/CT versus 29% in those with a positive iPET/CT ( I p i < 0.001) (Figure 1a). B Conclusion: b Response assessment by PET/CT at mid-induction can identify FL patients at high risk of failure early on during first line ICT and is able promptly select patients in whom maintenance therapy could be avoided. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text